SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-4,215 Cr | ₹-3,932 Cr | ₹-3,487 Cr | ₹-2,818 Cr | ₹-3,512 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-4,215 Cr |
| Mar2024 | ₹-3,932 Cr |
| Mar2023 | ₹-3,487 Cr |
| Mar2022 | ₹-2,818 Cr |
| Mar2021 | ₹-3,512 Cr |
How is Deferred Tax Assets / Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4,215 Cr | Negative | |
| Mar2024 | ₹-3,932 Cr | Negative | |
| Mar2023 | ₹-3,487 Cr | Negative | |
| Mar2022 | ₹-2,818 Cr | Negative | |
| Mar2021 | ₹-3,512 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,342.7 Cr | -2.8% | -1% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,543.0 Cr | -3.3% | 0.4% | -2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,884.0 Cr | -3.1% | 2.9% | 36.9% | Stock Analytics | |
| CIPLA | ₹111,077.0 Cr | -2.7% | 5.3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,388.0 Cr | -4.1% | -3.7% | 3.7% | Stock Analytics | |
| MANKIND PHARMA | ₹97,915.2 Cr | -5% | 2.3% | -5.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -2.8% |
-1% |
6.7% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses